Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma

MLA

Peter J. B. Sabatini, et al. “Validation of the RHL30 Digital Gene Expression Assay as a Prognostic Biomarker for Relapsed Hodgkin Lymphoma.” British Journal of HaematologyReferences, vol. 190, no. 6, Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30141f71560d80490770eca9a05a6d24&authtype=sso&custid=ns315887.

APA

Peter J. B. Sabatini, Michael Hong, Christian Steidl, Dean A. Regier, Wei Xu, Ho-Young Yhim, John Kuruvilla, Anca Prica, Tong Zhang, Lourdes Calvente, Rosemarie Tremblay-LeMay, Aly Karsan, Marco A. Marra, Michael Crump, Robert Kridel, Fong Chun Chan, Vishal Kukreti, & David Scott. (2020). Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma. British Journal of HaematologyReferences, 190(6).

Chicago

Peter J. B. Sabatini, Michael Hong, Christian Steidl, Dean A. Regier, Wei Xu, Ho-Young Yhim, John Kuruvilla, et al. 2020. “Validation of the RHL30 Digital Gene Expression Assay as a Prognostic Biomarker for Relapsed Hodgkin Lymphoma.” British Journal of HaematologyReferences 190 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30141f71560d80490770eca9a05a6d24&authtype=sso&custid=ns315887.